MNKD vs TFX: fair value comparison
MannKind Corporation and Teleflex Incorporated · Updated 2026-10-19
MNKD is still awaiting a full valuation verdict under our six-validated-windows standard. Within Healthcare, TFX currently ranks higher by quality score.
| MNKD | TFX | |
|---|---|---|
| Verdict | Awaiting full valuation | Undervalued |
| Last price | $3.04 | $126.11 |
| 12-month range | $2.28–$6.21 | $100.34–$142.05 |
| Rank by discount to fair value | — | #102 of 108 Healthcare |
| Rank by quality score | #110 of 301 Healthcare | #108 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | Low | Moderate |
| Margin trend | Stable | Contracting |
| Revenue growth | High | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | — |
| 52-week position | The bottom quarter | The upper-middle quarter |
Full single-stock breakdowns: MNKD fair value analysis · TFX fair value analysis